Endometrial DisorderNCT06763393
Correlation Between Adnexal Masses and Endometrial Thickness Measured With Ultrasound in Adults Women
An observational study of Endometrial Disorder, run by Superior University at 1 site in Pakistan.
Trial summary
This study explores the correlation between adnexal masses and endometrial thickness in adult women, using ultrasound as the primary diagnostic tool. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Endometrial Disorder
- What is being tested?
- Ultrasound
- Type of treatment
- Surgery or procedure
- How many people
- 90 participants
- Where
- 1 sitePakistan
- Study dates
- 28 Feb 2024to 1 Mar 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: to check the Correlation Between Adnexal Masses and Endometrial Thickness Measured With Ultrasound
Who may be able to join
- Adult women typically defined as those aged 18 and older.
- Women with diagnosed adnexal masses, which could be cysts, tumors, or other growths in the adnexa (ovaries and fallopian tubes).
Who cannot join
- Pregnant women might have different hormonal and physiological changes that can affect endometrial thickness and adnexal masses.
- Recent gynecological history.
Trial locations and contacts
1 site in 1 country.
About this study
This study explores the correlation between adnexal masses and endometrial thickness in adult women, using ultrasound as the primary diagnostic tool.
Read the detailed description
Adnexal masses, including ovarian cysts and other abnormalities, are common gynecological findings, while endometrial thickness is a crucial indicator for assessing conditions like endometrial hyperplasia or malignancy.
By analyzing ultrasound data, this research aims to determine whether the presence, size, or characteristics of adnexal masses have a significant relationship with variations in endometrial thickness.
- Conditions
- Endometrial Disorder
- Being tested
- Ultrasound
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
UltrasoundRadiation
To determine the correlation between adnexal masses and endometrial thickness measured with ultrasound in adults women.
What is being measured
The primary outcome is the main question the study is designed to answer.
ultrasound for Endometrial Thickness
Endometrial thickness is well assessed on MRI. Measurement should be taken at a mid-sagittal slice, similar to the ultrasound assessment plane
Measured: 12 Months
ultrasound radiopaedia for Adnexal Masses
Ultrasound (US) is an imaging technology that uses high-frequency sound waves to characterize tissue. It is a useful and flexible modality in medical imaging and often provides an additional or unique characterization of tissues
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jan 2025
- Study start28 Feb 2024
- Primary completion1 Aug 2024
- Study completion1 Mar 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Endometrial DisorderStudies of the same condition, open and under way.
- More trials run by Superior UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 90 participants (actual)
Sponsor and investigators
- Lead sponsor
- Superior University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Muhammad Naveed Babur, Superior University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06763393
- Sponsor's protocol ID
- MSAHS/Batch-Spring23/036
- Status last verified
- Jan 2025
- First submitted
- 18 Dec 2024
- Last updated
- 8 Jan 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Correlation Between Adnexal Masses and Endometrial Thickness Measured With Ultrasound in Adults Women
- ClinicalTrials.gov ID
- NCT06763393
- Acronym / sponsor ID
- MSAHS/Batch-Spring23/036
- Conditions
- Endometrial Disorder
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 90 participants (actual)
- Lead sponsor
- Superior UniversityUniversity, hospital or other
- Study start
- 28 Feb 2024 (actual)
- Primary completion
- 1 Aug 2024 (actual)
- Study completion
- 1 Mar 2025 (estimated)
- First posted
- 8 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study explores the correlation between adnexal masses and endometrial thickness in adult women, using ultrasound as the primary diagnostic tool.
Detailed description
Adnexal masses, including ovarian cysts and other abnormalities, are common gynecological findings, while endometrial thickness is a crucial indicator for assessing conditions like endometrial hyperplasia or malignancy.
By analyzing ultrasound data, this research aims to determine whether the presence, size, or characteristics of adnexal masses have a significant relationship with variations in endometrial thickness.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- to check the Correlation Between Adnexal Masses and Endometrial Thickness Measured With Ultrasound
Key inclusion criteria (2 listed)
- Adult women typically defined as those aged 18 and older.
- Women with diagnosed adnexal masses, which could be cysts, tumors, or other growths in the adnexa (ovaries and fallopian tubes).
Key exclusion criteria (2 listed)
- Pregnant women might have different hormonal and physiological changes that can affect endometrial thickness and adnexal masses.
- Recent gynecological history.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| UltrasoundTo determine the correlation between adnexal masses and endometrial thickness measured with ultrasound in adults women. | Radiation | – |
Primary outcome
ultrasound for Endometrial Thickness
Time frame: 12 Months
Endometrial thickness is well assessed on MRI. Measurement should be taken at a mid-sagittal slice, similar to the ultrasound assessment plane
ultrasound radiopaedia for Adnexal Masses
Time frame: 12 months
Ultrasound (US) is an imaging technology that uses high-frequency sound waves to characterize tissue. It is a useful and flexible modality in medical imaging and often provides an additional or unique characterization of tissues
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jan 2025.
Related trials for Endometrial Disorder
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Active, not recruitingPhase 3
Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
Endometrial Cancer
RecruitingPhase 3
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
RecruitingPhase 2
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma
RecruitingPhase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Endometrial Disorder, run by Superior University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 8 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
ultrasound for Endometrial Thickness (time frame: 12 Months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2025.